LRRK2 and ovarian cancer: Leucine-rich repeat kinase 2 (LRRK2), as a target of miR-205, has been introduced in another study of Liu et al. They showed that LRRK2 has lower expression in ovarian cancer tissues than in healthy ovarian tissues [212].